[Marital communication and depressive symptoms in couples in which the woman has cancer of the breast].

Abstract:

:If doctor-patient communication is a frequent subject of research, couples communication where one partner has cancer is quite recent. Some studies deal with couples communication, but from an anecdotic perspective, without any operational measure. The aim of this paper is to study couples' communication frequency and link it to depressive symptomatology. Marital communication was assessed with three scales: frequency of general communication, frequency of communication about cancer and satisfaction with communication. About one month following surgery, 120 breast cancer patients were interviewed; only 11 partners (9%) refused to be interviewed. Results show less communication is associated with higher depressive level. Patients and partners with a passable level of communication, particularly about cancer, are clinically at risk for depression. Communicating frequently about cancer in the couple seems thus associated with a positive effect, i.e. a depressive level found in the general population. Direction of causality between frequency of marital communication and depressive symptomatology cannot be established from this study.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Normand J,Lasry JC,Margolese RG,Perry JC,Fleiszer D

subject

Has Abstract

pub_date

2004-02-01 00:00:00

pages

193-9

issue

2

eissn

0007-4551

issn

1769-6917

journal_volume

91

pub_type

杂志文章
  • [The impact of gynaecological cancers on woman's sexuality and her couple].

    abstract::This article, devoted specifically to gynaecological cancers and their impact on the sexual and marital lives, is a collaboration between the psychologists and onco-gynaecologist within a cancer center. In oncology, gynaecological cancers' treatments involve at the same time anatomical, physiological and functional mo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.02.008

    authors: Vanlerenberghe E,Sedda AL,Ait-Kaci F

    更新日期:2015-05-01 00:00:00

  • [Clinical practice guidelines in cancerology: comparative study of three decision support-systems for breast and prostate cancer in Lorraine french region].

    abstract::Oncolor, the French regional cancer network of Lorraine, proposes clinical guidelines for the diagnosis, the treatment and the follow-up of cancers. In addition to paper documents, two computerized supports, a web site and the Kasimir software have been developed to make the use of these guidelines and their updating ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Rios M,Desandes E,Bresson B,Klein I,Lesur A,Boisson F,Demange V,Bey P

    更新日期:2003-04-01 00:00:00

  • [Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial].

    abstract::Seventy-five patients with locally advanced non small cell lung carcinoma were entered in a phase II study combining chemotherapy (vindesine, lomustine, cisplatin and cyclophosphamide) and radical thoracic radiotherapy delivering a total dose of 60-65 Gy. Patients were regularly assessed by radiological and fiberoptic...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Nasr E,Pellae-Cosset B,Arriagada R,Le Chevalier T,Baldeyrou P,Ruffie P,de Cremoux H,Martin M,Tarayre M

    更新日期:1992-01-01 00:00:00

  • [Neoadjuvant approach for non-metastatic rectal cancer combining radiotherapy and chemotherapy. Biotargeted drugs].

    abstract::Neoadjuvant chemoradiotherapy is considered at the present time as the standard treatment of most T3-4 rectal cancer. In France a combination of radiotherapy (45 Gy/5 weeks) with concurrent capecitabine (1,600 mg/m2) is the most popular protocol. Randomized trials try to optimize this approach using new cytotoxic drug...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.0838

    authors: Gérard JP,Francois E,Deustch E,Rostom Y,Douar N,Benezery K,Milano G

    更新日期:2009-03-01 00:00:00

  • [Evolving strategies over time for treatment of breast cancer].

    abstract::The natural history of breast diseases has changed overtime and successive therapeutic strategies have been adapted accordingly. Recently, biological findings on geno- and phenotypic characteristics of tumor cells offer new basis for the development of treatments that target homogenous and various subtypes of breast c...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1805

    authors: Roché H

    更新日期:2013-09-01 00:00:00

  • Chemoresistance in the clinic: overview 1994.

    abstract::One of the most exciting areas in clinical oncology today is the translation of laboratory research in drug resistance into therapeutic tools to improve responses to antineoplastic drugs. Two areas of investigation are currently under study in both the laboratory and clinic: reversal of gluthathione-mediated resistanc...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,评审

    doi:

    authors: Bates SE,Regis JI,Robey RW,Zhan Z,Scala S,Meadows BJ

    更新日期:1994-12-01 00:00:00

  • [The tobacco-cancer problem].

    abstract::Statistical, biological and chemical data on the carcinogenic effect of tobacco smoke are given and are discussed. The epidemiological studies have clearly shown the particularly noxious action of inhalation, and the direct ratio between the risk and the number of cigarettes smoked. The laboratory experiments on biolo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hubert-Habart M

    更新日期:1975-01-01 00:00:00

  • [Management of enzalutamide, a new hormonal therapy].

    abstract::Enzalutamide (MDV3100) is a non-steroidal antiandrogen of second generation that has shown efficacy in metastatic castration-resistant prostate cancer (mCRPC). The study AFFIRM demonstrated a statistically significant increase in overall survival among patients who have progressed following a docetaxel chemotherapy. B...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2013.1880

    authors: Beuzeboc P,Benderra MA,de La Motte Rouge T

    更新日期:2014-01-01 00:00:00

  • [Loco-regional treatments of the metastatic sites for patients with pauci-metastatic cutaneous melanoma (without brain metastasis): French national guidelines].

    abstract:INTRODUCTION:The last years are marked by the emergence of new molecules for the treatment of metastatic cutaneous melanoma with a significant benefit on the survival. Besides, some techniques are in development for the loco-regional treatment of the metastatic sites, bringing new therapeutic perspectives. However, the...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引

    doi:10.1684/bdc.2013.1868

    authors: Sassolas B,Mourrégot A,Thariat J,Tiffet O,Dygai-Cochet I,Mirabel X,Truc G,Cupissol D,Modiano P,Combemale P,Bedane C,Derrey S,Lamant L,Lubrano V,Siegrist S,Rougé-Bugat MÈ,Mazeau-Woynar V,Verdoni L,Planchamp F,Leccia

    更新日期:2014-01-01 00:00:00

  • Medical practices and cancer care networks: examples in oncology.

    abstract::Understanding medical practices or the whys and wherefores of care decision-making is among the major objectives of medical, economic and sociological research in the current political environment. Although variations of medical practice have long been known to exist, causes and deciding factors remain obscure. This i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Ray-Coquard I,Chauvin F,Lurkin A,Ducimetière F,Jacquin JP,Agostini C,Pouchard I,Meyer B,Farsi F,Castel P,Perrier L,Philip T

    更新日期:2006-02-01 00:00:00

  • [Chemotherapeutic intensification in germ cell tumors].

    abstract::Chemotherapy has dramatically improved the prognosis of non-seminomatous germ cell tumors (NSGCT). However, some patients relapse and others are refractory to first line chemotherapy. We studied a salvage chemotherapeutic regimen with etoposide 75 gm/m2/day, and cisplatin 40 mg/m2/day, days 1-5 and Ifosfamide 3 g/m2/d...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Droz JP,Pico JL,Ghosn M,Ostronoff M,Azab M,Theodore C,Hayat M

    更新日期:1990-01-01 00:00:00

  • Quality of care assessment for breast cancer: how to measure benefits of prevention and therapy in oncology.

    abstract::Over the last few years evaluation of quality of diagnostic and therapeutic care has become one of the most controversial and fastest growing fields of research in many areas of medicine. In this situation, oncology represents a model case as the conditions in which new therapeutic strategies are tested and implemente...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Liberati A,Fossati R,Torri W

    更新日期:1987-01-01 00:00:00

  • [Analysis of the growth kinetics of autochthonous DMBA-induced tumors in mice of various ages and sex].

    abstract::In order to understand the kinetics of this experimental model, we studied the influence of age and sex on primary tumoral and pulmonary metastatic yields and on the growth kinetics parameters. Connective tissue tumors were induced by DMBA in male and female Swiss mice of various ages (pre and postpubertal, adult and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Vrignaud P,Denechaud M

    更新日期:1985-01-01 00:00:00

  • [Measurement of the kinetics of cell proliferation of cancer of the oropharynx in vivo by the incorporation of bromodeoxyuridine and flow cytometry].

    abstract::Forty-six tumors from patients with oropharyngeal carcinoma were analysed by flow cytometry after injection of bromodeoxyuridine (Budr) for the labelling index, the duration of S phase and the potential doubling time (Tpot). The results show large variations in Tpot (from 2.6 to 16.7 days) among these tumors from the ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bourhis J,Wilson GD,Janot F,Chavaudra N,Leridant AM,Wibault P,Girinsky T,Luboinski B,Eschwege F,Malaise EP

    更新日期:1991-11-01 00:00:00

  • [Allorecognition of the recipient after hematopoietic transplantation].

    abstract::Donor allorecognition of the recipient after hematopoietic transplantation can result in graft-versus-host disease, a potent graft-vs-leukemia effect as well as a graft facilitation effect. Danger signals, host Ag-presenting cells and minor histocompatibility Ag have recently emerged as major determinants of such an a...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Tiberghien P,Robinet E,Ferrand C,Saas P,Hervé P

    更新日期:2003-08-01 00:00:00

  • [Breast cancer's impact on work life. Survey among women of the ELIPPSE cohort].

    abstract::Working people who are diagnosed with cancer must generally stop working, and returning to work after treatment is a very important issue for them. This article investigates the impact of cancer on professional trajectory among working women after a breast cancer diagnosis. We conducted in-depth interviews with 21 wom...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2012.1611

    authors: Gallardo L,Rey D,Peretti-Watel P

    更新日期:2012-07-01 00:00:00

  • Early diagnosis of gastrointestinal cancer.

    abstract::The earlier a gastro-intestinal cancer is treated the better will be the prospects of cure for the patient. It is therefore important to study the early clinical stages of the pathway which leads to the diagnosis of gastro-intestinal cancer in order to make this pathway short and quick. This paper identifies the delay...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mac Adam DB

    更新日期:1980-01-01 00:00:00

  • [Pharmacologic bases of chemotherapy of brain tumors in children].

    abstract::In terms of pharmacology, drug delivery is an important obstacle in the development of brain tumor chemotherapy. The blood-brain barrier limits the drug penetration in normal brain tissue around the tumor and at distant potential metastatic sites. In the tumor, the altered blood-brain barrier, ie blood-tumor barrier, ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Vassal G

    更新日期:1990-01-01 00:00:00

  • [Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens].

    abstract:CONTEXT:The "Standards, Options and Recommendations" (SOR) collaborative project was initiated in 1993 by the Federation of the French Cancer Centres (FNCLCC), with the 20 French Regional Cancer Centres, several French public university and general hospitals, as well as private clinics and medical specialty societies. ...

    journal_title:Bulletin du cancer

    pub_type: 指南,杂志文章,实务指引

    doi:

    authors: Denoux Y,Blanc-Vincent MP,Simony-Lafontaine Jl,Verriele-Beurrier V,Briffod M,Voigt JJ

    更新日期:2002-04-01 00:00:00

  • [Doxifluridine toxicity, a fluorouracil analog with low myelosuppressive effect].

    abstract::Doxifluridine, a new fluorouracil analog with a low myelosuppressive effect, has recently been subject to various disease-oriented, Phase II trials. For the present evaluation of drug tolerance, the Phase II data of 114 patients having received 376 doxifluridine cycles has been used. The treatment cycles consisted of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Winkelmann JJ,Alberto P,Mermillod B

    更新日期:1990-01-01 00:00:00

  • [Pharmacological consequences of the targeting of epidermal growth factor receptor].

    abstract::Through clearly identified molecular mechanisms, EGFR targeting leads to cell physiology modifications as cell proliferation, apoptosis and DNA repair. These mechanisms can explain the proper activity of EGFR targeting drugs but also represent a strong rational basis on which several experimental studies have been des...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Milano G,Magné N

    更新日期:2003-11-01 00:00:00

  • [Study of codon 72 of p53 gene as a risk-factor in cervical cancer in Senegal].

    abstract::Beside human papilloma virus infection, several genetic factors have been involved in susceptibility to cervical cancer. The arginine allele at codon 72 in p53 tumor suppressor gene has been reported to be a risk-factor in different ethnic groups. Our aim was to study this polymorphism as a risk-factor in Senegal. We ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.1911

    authors: Ndiaye R,Dem A,Mbaye PM,Guèye PM,Diop G,Diop PA,Faye O

    更新日期:2014-09-01 00:00:00

  • [Larynx cancer in France: descriptive epidemiology and incidence estimation].

    abstract::The epidemiology of cancers is known in France through mortality data provided by Inserm and morbidity data obtained by French tumor registries. The purpose of this study was to compare the incidence of laryngeal cancers in 9 French departments and to give an estimate of this incidence for the whole of France, based o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Peng J,Ménégoz F,Lesec'h JM,Remontet L,Grosclaude P,Buémi A,Guizard AV,Tretarre B,Danzon A,Velten M,Maarouf N,Jougla E,Launoy G,Dubreuil A

    更新日期:2004-04-01 00:00:00

  • [Patients' information in percutaneous core breast biopsy].

    abstract::Information takes a large part of patient's perceptions of the procedure. If the information is adapted, patients tolerate the procedure well. We point out indications and explain the different types of procedure. For infraclinical masses, sonographically guided automated core needle biopsy removes samples. Sonographi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Barreau B,Tastet S,Lakdja F,Henriquès C,Valentin F,Labat MJ,Dilhuydy MH

    更新日期:2005-03-01 00:00:00

  • [Hodgkin disease: should high-risk patients be selected and chemotherapy be intensified?].

    abstract::Death still occurs in Hodgkin's disease (HD) patients with advanced stages, but also in early stages. Therefore, the identification of the population of HD patients who would best benefit from an intensification of treatment is a prerequisite in all stages. The best known prognostic factors are bulky mediastinum, B sy...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Carde P

    更新日期:1995-08-01 00:00:00

  • Bone marrow transplantation for acute leukemia.

    abstract::Since the results of bone marrow transplantation for acute leukemia in relapse have been poor (less than 20% long term survival), an attempt of bone marrow transplantation for acute leukemia in remission has been performed since 1976 by the Seattle Group. The results are very encouraging. In ANL transplanted in first ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Buckner CD

    更新日期:1981-01-01 00:00:00

  • [Renal failure after allogeneic hematopoietic stem cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].

    abstract::Acute and chronic renal failures are very common after allogeneic HSCT. These complications have a real impact on mortality and morbidity of transplant recipients. Within the framework of the ninth workshops of practice harmonization of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引

    doi:10.1016/j.bulcan.2019.05.002

    authors: Detrait M,de Berranger E,Dulery R,Ménard AL,Thépot S,Toprak SK,Turlure P,Yakoub-Agha I,Guillaume T

    更新日期:2020-01-01 00:00:00

  • [The Stockholm preoperative radiotherapy of operable breast cancer. Preliminary report].

    abstract::The 4 year results of a prospective clinical trial on the treatment of operable breast cancer, comparing the effects of preoperative radiotherapy followed by surgery with those of surgery followed or not by postoperative radiotherapy are presented for patient groups of approximately 100 each. At 4 years 85 per cent su...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Wallgren A,de Schryver A,Wasserman J

    更新日期:1977-01-01 00:00:00

  • [Use of complementary medicine by cancer patients in a French oncology department].

    abstract::The aims of this study was to estimate and describe the reasons of use of complementary medicine in patients with a cancer treated in a French oncology department. An anonymous questionnaire was proposed to patients during treatment or follow-up in an oncology department. It was a descriptive study over 207 questionna...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Träger-Maury S,Tournigand C,Maindrault-Goebel F,Afchain P,de Gramont A,Garcia-Larnicol ML,Gervais H,Louvet C

    更新日期:2007-11-01 00:00:00

  • [Supportive care for survivors].

    abstract::Advances in early detection and treatment have pushed in a few decades the management of cancers from a management model of the end of life to the management of a chronic disease. This evolution has accelerated the development of supportive care in two directions, firstly towards the best possible support to the end o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.04.007

    authors: Ninot G,Debourdeau P,Blanc-Legier F,De Crozals F,De Rauglaudre G,Khouri S,Kirscher S,Mineur L,Piollet I,Sant I,Schillinger P,Serin D

    更新日期:2018-09-01 00:00:00